期刊
JOURNAL OF NUCLEAR MEDICINE
卷 56, 期 12, 页码 1823-1827出版社
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.115.160648
关键词
integrin; Ga-68-NOTA-PRGD2; PET/CT; lung cancer; lymph node metastasis
资金
- Capital Special Project for Featured Clinical Application [Z121107001012119]
- National Natural Science Foundation of China project [81171369, 81171370, 81371596, 81271614]
- Ministry of Education of China [311037]
- Young Scientist Research Funding of Peking Union Medical College Hospital [PUMCH2013]
- Intramural Research Program (IRP) of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH)
This study was designed to assess the diagnostic value of 68Ga-NOTA-PRGD2 (NOTA-PRGD2 is NOTA-PEG4-E[c(RGDfK)](2)) PET/CT in lung cancer. Methods: Ninety-one patients (48 men and 43 women; age, 22-82 y) with suspected lung lesions on CT were enrolled with informed consent. Immediately after intravenous injection of 117.7 +/- 37.7 MBq of Ga-68-NOTA-PRGD2, 15 patients underwent dynamic whole-body PET/CT scans for 1-2 h, and the remaining 76 patients underwent whole-body PET/CT scans at 30 +/- 10 min after bolus injection. Each patient also underwent standard F-18-FDG PET/CT for comparison. Results: No side effect was found after Ga-68-NOTA-PRGD2 injection. Ga-68-NOTA-PRGD2 was rapidly cleared from the blood pool and primarily excreted through the urinary system. The standardized uptake values of proven malignancies were significantly higher than those of the benign ones. With an average standardized uptake value of greater than 1.3 being considered malignant, the sensitivity, specificity, and accuracy of Ga-68-NOTA-PRGD2 PET/CT in diagnosing lung cancer were 83.8% (57/68), 91.3%(21/23), and 85.7%(78/91), respectively. The diagnostic value of Ga-68-NOTA-PRGD2 for lung cancer is comparable to that of F-18-FDG PET/CT. However, Ga-68-NOTA-PRGD2 PET/CT is more specific than F-18-FDG PET/CT in assessing lymph node metastasis, with positive and negative predictive values of 90.0% (27/30) and 93.8% (121/129), respectively, whereas those of F-18-FDG PET/CT were 30.2% (29/96) and 90.5% (57/63), respectively. Conclusion: This study indicates the efficacy of Ga-68-NOTA-PRGD2 PET/CT in lung cancer diagnosis. 68Ga-NOTA-PRGD2 PET/CT shows significant advantage over F-18-FDG PET/CT in judging metastatic lymph nodes with higher specificity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据